2017
DOI: 10.4244/eij-d-16-00816 View full text |Buy / Rent full text
|
|

Abstract: In this large multicentre randomised trial, the GSS6Fr was associated with a low event rate for the primary endpoint (RAO), although non-inferiority to the GS5Fr was not met, due to a lower than expected rate of RAO in the GS5Fr group. As compared to institutional haemostasis, the use of patent haemostasis was not associated with a reduced rate of RAO.

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
21
0
6

Publication Types

Select...

Relationship

0
0

Authors

Journals